Supply Chain

Here are the seven latest drugs or medical devices approved by the FDA since May 24.

The FDA approved the first standalone prosthetic iris in the U.S. May 30.

The FDA on May 30 expanded the approval for Pfizer's drug Xeljanz.

Seven Nebraska patrolmen helped relay a hard-to-find drug 540 miles from Omaha-based University of Nebraska Medical Center to a hospital in Colorado after stormy weather prevented the medication from being flown to its destination, according to a KWBE report.

Global antibiotic shortages, caused by a fragile drug supply chain, are contributing to the rise of multidrug-resistant bacteria known as superbugs, according to a report from the Access to Medicine Foundation.

President Donald Trump expects pharmaceutical companies to significantly lower drug prices over the next few weeks, according to Reuters.

How Boston-based Massachusetts General Hospital is dealing with the ongoing intravenous opioid shortage most captured readers' attention in May.

The FDA approved TherapeuticsMD's hormone therapy Imvexxy for a vaginal condition linked to low estrogen levels during menopause, the company announced May 30.

Actress Roseanne Barr claims her controversial tweet about Valerie Jarrett, a White House aide during the Obama administration, was due to her taking Sanofi's insomnia drug Ambien, reports CNN.

Amazon on May 29 earned a patent outlining the various methods its delivery drones could use to signal their approach and interact with customers expecting packages, reports GeekWire.